Hydrocodone/acetaminophen 5-325 Tb

Manufacturer AMNEAL PHARMACEUTICALS Active Ingredient Hydrocodone and Acetaminophen Tablets and Capsules(hye droe KOE done & a seet a MIN oh fen) Pronunciation hye droe KOE done & a seet a MIN oh fen
WARNING: This drug has an opioid drug in it. Opioid drugs can put you at risk for drug use disorder. Misuse or abuse of this drug can lead to overdose and death. If you have questions, talk with your doctor.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing.Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.This drug has acetaminophen in it. Liver problems have happened with the use of acetaminophen. Sometimes, this has led to a liver transplant or death. Most of the time, liver problems happened in people taking more than 4,000 mg (milligrams) of acetaminophen in a day. People were also often taking more than 1 drug that had acetaminophen.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life- threatening if not treated. @ COMMON USES: It is used to manage pain when non- opioid pain drugs do not treat your pain well enough or you cannot take them.
🏷️
Drug Class
Opioid analgesic combination
🧬
Pharmacologic Class
Opioid agonist; Para-aminophenol derivative
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Mar 1983
βš–οΈ
DEA Schedule
Schedule II

Overview

ℹ️

What is this medicine?

This medication is a combination of two pain relievers: hydrocodone, which is an opioid (narcotic) pain reliever, and acetaminophen, a non-opioid pain reliever. It is used to treat moderate to moderately severe pain.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To ensure safe and effective use of this medication, follow your doctor's instructions carefully. Read all accompanying information and adhere to the prescribed regimen.

Take this medication orally only, with or without food. If it causes stomach upset, take it with food to help alleviate discomfort.
Do not inject or snort this medication, as this can lead to severe side effects, including respiratory distress and potentially fatal overdose.
Adhere to the prescribed dosage and frequency. Do not exceed the recommended dose, and do not take it more frequently or for a longer duration than instructed. Deviating from the prescribed regimen may increase the risk of severe side effects.
Avoid concomitant use of this medication with other strong pain medications or pain patches without consulting your doctor first.
* If your pain worsens, you experience increased sensitivity to pain, or you develop new pain after taking this medication, contact your doctor immediately. Do not take additional doses beyond what is prescribed.

Important Interactions and Precautions

This medication may interfere with certain laboratory tests. Inform all healthcare providers and laboratory personnel that you are taking this medication.

Storage and Disposal

Store this medication at room temperature in a dry location, avoiding storage in bathrooms. Keep it in a secure, inaccessible location, such as a locked box or area, to prevent accidental ingestion by children or unauthorized access. Keep all medications out of reach of pets.

Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. Consult your pharmacist for guidance on safe disposal methods, and explore potential drug take-back programs in your area.

Missed Doses

If you take this medication on a regular schedule, take the missed dose as soon as you remember. If it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take double doses or extra doses. If you take this medication on an as-needed basis, do not exceed the frequency recommended by your doctor.
πŸ’‘

Lifestyle & Tips

  • Do not drink alcohol while taking this medication, as it can increase the risk of serious side effects like extreme drowsiness and breathing problems.
  • Avoid driving or operating heavy machinery until you know how this medication affects you, as it can cause dizziness and drowsiness.
  • To prevent constipation, drink plenty of fluids, eat fiber-rich foods, and consider using a stool softener or laxative as directed by your doctor.
  • Store this medication securely away from children and pets, as accidental ingestion can be fatal.
  • Do not share this medication with anyone else, even if they have similar symptoms, as it can be dangerous and is against the law.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: 1 to 2 tablets (hydrocodone 5-10 mg, acetaminophen 325-650 mg) orally every 4 to 6 hours as needed for pain
Dose Range: 5 - 10 mg

Condition-Specific Dosing:

maximumDailyDose: Maximum 8 tablets (40 mg hydrocodone, 3250 mg acetaminophen) per 24 hours for 5-325 mg strength.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not recommended for routine use due to risk of respiratory depression and accidental overdose. If used, extreme caution and individualized dosing based on weight and age, typically for children >6 years old, with close monitoring.
Adolescent: Use with caution; individualized dosing based on weight and age, typically starting with lower doses and titrating as needed. Max acetaminophen dose must be considered.
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: No specific adjustment, monitor for increased sedation.
Moderate: Use with caution, consider dose reduction and extended dosing interval. Monitor for accumulation of hydrocodone and acetaminophen metabolites.
Severe: Contraindicated or significantly reduced dose and extended interval. Monitor closely for respiratory depression and hepatotoxicity.
Dialysis: Hydrocodone and its metabolites are not significantly removed by hemodialysis. Acetaminophen is dialyzable. Use with caution, consider dose reduction and extended interval.

Hepatic Impairment:

Mild: Use with caution, consider dose reduction, especially for acetaminophen component.
Moderate: Use with caution, significant dose reduction recommended for acetaminophen. Monitor liver function closely.
Severe: Contraindicated due to risk of severe hepatotoxicity from acetaminophen and increased opioid sensitivity.
Confidence: Medium

Pharmacology

πŸ”¬

Mechanism of Action

Hydrocodone is a semisynthetic opioid analgesic that acts as an agonist at mu-opioid receptors in the central nervous system (CNS), producing analgesia, sedation, and respiratory depression. Acetaminophen is a non-opioid analgesic and antipyretic, believed to act primarily through central inhibition of prostaglandin synthesis (COX-3 inhibition) and possibly through modulation of the serotonergic descending pain pathways.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Hydrocodone: ~60-70%; Acetaminophen: ~60-90%
Tmax: Hydrocodone: ~1.3 hours; Acetaminophen: ~0.5-2 hours
FoodEffect: Food may slightly delay Tmax but does not significantly affect the extent of absorption.

Distribution:

Vd: Hydrocodone: ~2.2-4.5 L/kg; Acetaminophen: ~0.95 L/kg
ProteinBinding: Hydrocodone: ~20-50%; Acetaminophen: ~10-25%
CnssPenetration: Yes

Elimination:

HalfLife: Hydrocodone: ~3.8 hours; Acetaminophen: ~1-4 hours
Clearance: Not available
ExcretionRoute: Renal (primarily as metabolites)
Unchanged: Hydrocodone: <10%; Acetaminophen: <5%
⏱️

Pharmacodynamics

OnsetOfAction: Oral: ~10-30 minutes
PeakEffect: Oral: ~30-60 minutes
DurationOfAction: Oral: ~4-6 hours
Confidence: Medium

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF ADDICTION, ABUSE, AND MISUSE: Hydrocodone/acetaminophen exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing hydrocodone/acetaminophen, and monitor all patients receiving hydrocodone/acetaminophen for the development of these behaviors and conditions.

OPIOID ANALGESIC RISK EVALUATION AND MITIGATION STRATEGY (REMS): To ensure that the benefits of opioid analgesics outweigh the risks of addiction, abuse, and misuse, the FDA has required a REMS for these products. Under the requirements of the REMS, drug companies with approved opioid analgesic products must make REMS-compliant education programs available to healthcare providers.

RESPIRATORY DEPRESSION: Serious, life-threatening, or fatal respiratory depression may occur. Monitor for respiratory depression, especially during initiation of hydrocodone/acetaminophen or following a dose increase.

ACCIDENTAL INGESTION: Accidental ingestion of even one dose of hydrocodone/acetaminophen, especially by children, can result in a fatal overdose of hydrocodone.

NEONATAL OPIOID WITHDRAWAL SYNDROME: Prolonged use of hydrocodone/acetaminophen during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts. If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.

CYTOCHROME P450 3A4 INTERACTION: The concomitant use of hydrocodone/acetaminophen with all cytochrome P450 3A4 inhibitors may result in increased hydrocodone plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in increased hydrocodone plasma concentration. Monitor patients receiving hydrocodone/acetaminophen and any CYP3A4 inhibitor or inducer.

HEPATOTOXICITY: Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant or death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 mg per day, and often involve more than one acetaminophen-containing product. Ensure that the total daily dose of acetaminophen does not exceed 4000 mg.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Immediately

Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention right away:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or passing out
Clammy skin
Excessive sweating
Confusion
Trouble walking
Severe constipation or stomach pain, which may indicate a severe bowel problem
Hearing loss or changes in hearing
Chest pain or pressure
Abnormal heartbeat (fast or slow)
Breathing difficulties, including:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Mood changes
Trouble urinating
Changes in urination patterns
Vision changes
Seizures
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other severe skin reactions, which can be life-threatening
Signs of serotonin syndrome, a potentially life-threatening condition, including:
+ Agitation
+ Balance problems
+ Confusion
+ Hallucinations
+ Fever
+ Abnormal heartbeat
+ Flushing
+ Muscle twitching or stiffness
+ Seizures
+ Shivering or shaking
+ Excessive sweating
+ Severe diarrhea
+ Upset stomach or vomiting
+ Severe headache

Other Possible Side Effects

Most people taking this medication do not experience severe side effects. However, some may encounter mild or moderate side effects, including:

Constipation
Upset stomach or vomiting
Stomach pain or heartburn
Dizziness
Drowsiness
Fatigue
Headache

If you experience any of these side effects or any other unusual symptoms, contact your doctor for advice. They can help you manage your symptoms and determine the best course of action.

Reporting Side Effects

If you have questions or concerns about side effects, you can:

Contact your doctor for medical advice
Report side effects to the FDA at 1-800-332-1088
Submit a report online at https://www.fda.gov/medwatch
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow, shallow, or difficult breathing
  • Extreme drowsiness or difficulty waking up
  • Bluish lips or fingernails
  • Severe dizziness or lightheadedness
  • Confusion or disorientation
  • Yellowing of the skin or eyes (jaundice)
  • Dark urine or clay-colored stools
  • Severe stomach pain or nausea/vomiting that doesn't go away
  • Signs of an allergic reaction (rash, itching, swelling of face/tongue/throat, severe dizziness, trouble breathing)
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel blockage or narrowing
Other medications you are currently taking, particularly:
+ Buprenorphine
+ Butorphanol
+ Linezolid
+ Methylene blue
+ Nalbuphine
+ Pentazocine
If you have taken any medications for depression or Parkinson's disease within the last 14 days, including:
+ Isocarboxazid
+ Phenelzine
+ Tranylcypromine
+ Selegiline
+ Rasagiline (note: taking this medication with these drugs can lead to very high blood pressure)

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have. This will help ensure your safety while taking this medication. Never start, stop, or change the dose of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

Important Warnings and Cautions

Inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Avoid driving and performing tasks that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position and exercise caution when climbing stairs.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, consult your doctor. Do not exceed the prescribed dose.

Additionally, regular use of opioid medications like this one can cause dependence. If you need to reduce the dose or stop taking this medication, consult your doctor first, as sudden changes may increase the risk of withdrawal or other severe problems. Follow your doctor's instructions carefully and report any adverse effects, such as increased pain, mood changes, suicidal thoughts, or other concerns.

Interactions with Other Substances
Do not consume alcohol or products containing alcohol while taking this medication, as this can lead to unsafe and potentially fatal interactions.

Acetaminophen Precautions
Avoid taking other products that contain acetaminophen, and carefully check the labels of all medications. Exceeding the recommended daily dose of acetaminophen can cause liver damage. Follow the dosage instructions exactly, and do not take more than 4,000 mg (milligrams) of acetaminophen per day unless directed by your doctor. Certain individuals, such as those with liver problems or children, may require lower doses. If you are unsure about the safe dose for you, consult your doctor or pharmacist. If you suspect you have taken too much acetaminophen, contact your doctor immediately, even if you feel well.

Liver Problem Warning Signs
Monitor for signs of liver problems, such as dark urine, fatigue, decreased appetite, nausea, stomach pain, pale stools, vomiting, or yellowing of the skin and eyes. If you experience any of these symptoms, contact your doctor promptly.

Hormonal and Adrenal Gland Effects
Long-term use of opioid medications like this one can lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation difficulties, consult your doctor.

Additionally, taking an opioid medication like this one can cause a rare but severe adrenal gland problem. If you experience extreme fatigue, weakness, fainting, severe dizziness, nausea, vomiting, or decreased appetite, contact your doctor immediately.

Seizure Risk
This medication may increase the risk of seizures in some individuals, particularly those with a history of seizures. Discuss your risk with your doctor.

Age-Related Precautions
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Breastfeeding Precautions
If you are breastfeeding, inform your doctor, as this medication can pass into breast milk and harm your baby. Seek medical attention immediately if your baby appears excessively sleepy, limp, or has breathing difficulties.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Slowed or stopped breathing
  • Extreme drowsiness, unresponsiveness, or coma
  • Pinpoint pupils
  • Cold, clammy skin
  • Limp muscles
  • Bluish discoloration of lips and fingernails
  • Nausea, vomiting, abdominal pain (acetaminophen overdose)

What to Do:

Seek immediate emergency medical attention. Call 911 or your local poison control center (1-800-222-1222). If naloxone (Narcan) is available, administer it if the person is unresponsive or has severe breathing problems, and continue to monitor until emergency help arrives.

Drug Interactions

🚫

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) within 14 days (risk of serotonin syndrome, respiratory depression, coma, death)
  • Severe respiratory depression
  • Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment
  • Known or suspected paralytic ileus
  • Hypersensitivity to hydrocodone, acetaminophen, or any component of the formulation
πŸ”΄

Major Interactions

  • Other CNS depressants (e.g., benzodiazepines, other opioids, alcohol, sedatives, hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants): Additive CNS depression, respiratory depression, hypotension, profound sedation, coma, death.
  • CYP3A4 inhibitors (e.g., macrolide antibiotics, azole antifungals, protease inhibitors): Increased hydrocodone plasma concentrations, leading to increased opioid effects and potential for fatal respiratory depression.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine, bupropion): Decreased conversion of hydrocodone to hydromorphone, potentially reducing analgesic effect.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol, fentanyl, linezolid, St. John's Wort): Risk of serotonin syndrome.
  • Anticholinergic drugs (e.g., atropine, scopolamine, antihistamines): Increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.
  • Mixed agonist/antagonist and partial agonist opioids (e.g., pentazocine, nalbuphine, butorphanol, buprenorphine): May precipitate opioid withdrawal symptoms or reduce analgesic effect.
🟑

Moderate Interactions

  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin): Decreased hydrocodone plasma concentrations, potentially reducing analgesic effect and leading to withdrawal symptoms in opioid-dependent patients.
  • Diuretics: Opioids may reduce the efficacy of diuretics by causing the release of antidiuretic hormone.
  • Antihypertensives: Opioids may cause orthostatic hypotension, additive effect with antihypertensives.
  • Warfarin: Acetaminophen may potentiate the anticoagulant effect of warfarin with chronic high doses, increasing bleeding risk.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pain assessment (intensity, location, quality)

Rationale: To establish baseline pain level and guide initial dosing.

Timing: Prior to initiation of therapy

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk for respiratory depression.

Timing: Prior to initiation of therapy

Level of consciousness/sedation

Rationale: To assess baseline neurological status and identify risk for excessive sedation.

Timing: Prior to initiation of therapy

Liver function tests (ALT, AST, bilirubin)

Rationale: To assess baseline hepatic function, especially important for acetaminophen component and in patients with pre-existing liver disease.

Timing: Prior to initiation of therapy, particularly if chronic use is anticipated or liver disease is suspected.

Renal function (BUN, creatinine)

Rationale: To assess baseline renal function, as metabolites are renally excreted.

Timing: Prior to initiation of therapy, particularly if chronic use is anticipated or renal impairment is suspected.

πŸ“Š

Routine Monitoring

Pain relief and functional improvement

Frequency: Regularly during therapy (e.g., daily or as needed)

Target: Acceptable pain level, improved function

Action Threshold: Inadequate pain control or worsening pain may require dose adjustment or alternative therapy.

Respiratory rate and depth

Frequency: Regularly, especially during initiation and dose titration, or if sedation occurs.

Target: >10-12 breaths/min, regular rhythm

Action Threshold: <10 breaths/min, shallow breathing, or signs of hypoventilation require immediate intervention (e.g., naloxone, respiratory support).

Level of consciousness/sedation (e.g., Pasero Opioid-Induced Sedation Scale)

Frequency: Regularly, especially during initiation and dose titration.

Target: Alert or mildly drowsy, easily aroused

Action Threshold: Moderately to excessively sedated, difficult to arouse, or unarousable requires immediate intervention.

Bowel function (constipation)

Frequency: Daily

Target: Regular bowel movements

Action Threshold: No bowel movement for >2-3 days, severe straining, or abdominal discomfort may require laxative intervention.

Signs of liver toxicity (jaundice, dark urine, abdominal pain)

Frequency: Periodically, especially with chronic use or higher doses of acetaminophen.

Target: Normal liver function

Action Threshold: Elevated LFTs, signs of liver injury require discontinuation and medical evaluation.

Signs of opioid abuse, misuse, or addiction

Frequency: Ongoing assessment during therapy

Target: Appropriate use of medication

Action Threshold: Aberrant drug-taking behaviors, escalating doses, or seeking multiple prescribers require intervention and referral.

πŸ‘οΈ

Symptom Monitoring

  • Excessive sedation
  • Difficulty breathing or shallow breathing
  • Confusion or disorientation
  • Dizziness or lightheadedness
  • Severe constipation
  • Nausea and vomiting
  • Abdominal pain
  • Yellowing of skin or eyes (jaundice)
  • Dark urine
  • Unusual tiredness or weakness

Special Patient Groups

🀰

Pregnancy

Category C. Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome (NOWS), which can be life-threatening if not recognized and treated. Use only if the potential benefit justifies the potential risk to the fetus.

Trimester-Specific Risks:

First Trimester: Potential for congenital malformations (e.g., neural tube defects, cardiac defects, oral clefts) with opioid exposure, though data are mixed. Acetaminophen is generally considered safe for occasional use.
Second Trimester: Risk of NOWS increases with prolonged exposure. Risk of respiratory depression in the neonate if used close to delivery.
Third Trimester: High risk of NOWS with prolonged use. Risk of respiratory depression in the neonate if used close to delivery. Risk of premature birth and low birth weight.
🀱

Lactation

Hydrocodone and its active metabolite hydromorphone are present in breast milk. Acetaminophen is also excreted in breast milk. Risk of serious adverse reactions in breastfed infants, including sedation, respiratory depression, and death. Not recommended for breastfeeding mothers. If use is unavoidable, monitor infant closely for signs of sedation, difficulty feeding, and breathing problems. Consider pumping and discarding milk or using an alternative analgesic.

Infant Risk: L3 (Moderate risk). Potential for sedation, respiratory depression, poor feeding, and developmental delay in the infant. Risk is higher in infants of mothers who are ultra-rapid metabolizers of hydrocodone.
πŸ‘Ά

Pediatric Use

Not recommended for children under 6 years of age due to the risk of fatal respiratory depression. Use in older children should be with extreme caution, individualized dosing, and close monitoring due to variability in CYP2D6 metabolism and increased sensitivity to opioids. Acetaminophen dosing in children must be carefully calculated by weight.

πŸ‘΄

Geriatric Use

Elderly patients may be more sensitive to the analgesic and adverse effects of opioids, including respiratory depression, sedation, and constipation. Start with lower doses and titrate slowly. Monitor renal and hepatic function closely.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Always verify the acetaminophen content to ensure the total daily dose does not exceed 4000 mg (or 3000 mg in some guidelines/patients with liver risk) from all sources.
  • Educate patients on the risks of addiction, abuse, and misuse, and the importance of safe storage and disposal.
  • Warn patients about the dangers of combining this medication with alcohol or other CNS depressants.
  • Monitor for signs of respiratory depression, especially during initiation or dose escalation, and ensure naloxone availability if appropriate.
  • Counsel patients on strategies to manage opioid-induced constipation.
  • Be aware of potential drug interactions, especially with CYP3A4 inhibitors/inducers and serotonergic drugs.
  • Consider the patient's pain type and duration; this combination is best suited for acute, moderate to moderately severe pain where non-opioid options are insufficient.
πŸ”„

Alternative Therapies

  • NSAIDs (e.g., ibuprofen, naproxen)
  • Acetaminophen (single agent)
  • Other non-opioid analgesics (e.g., gabapentin, pregabalin for neuropathic pain)
  • Topical analgesics
  • Physical therapy
  • Interventional pain procedures
  • Other opioid analgesics (e.g., morphine, hydromorphone, oxycodone, tramadol) as single agents, if appropriate.
πŸ’°

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (generic)
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen, contact your doctor immediately. It is essential to use your medication responsibly: do not share it with others, and never take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its safe use. Read this guide carefully when you first receive your medication, and review it again each time your prescription is refilled. If you have any questions or concerns about your medication, consult your doctor, pharmacist, or other healthcare provider.

In the event of an overdose, a medication called naloxone can be administered to help counteract the effects. Discuss obtaining and using naloxone with your doctor or pharmacist. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide information about the overdose, including the substance taken, the amount, and the time it occurred.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care right away. When seeking help, be prepared to provide detailed information about the overdose, including what was taken, the quantity, and the time of the incident.